However, in the late-stage AD brain or in cortical organoids with long-term AD pathology there is instead a significant decrease in the number of PLIN3 + LDs, indicating a diverse metabolic dysregulation of this specific LD population over time. This evidence concerns the gene PLIN3 and Alzheimer disease.